β-arrestin 2 regulates Aβ generation and γ-secretase activity in Alzheimer's disease

被引:0
作者
Amantha Thathiah
Katrien Horré
An Snellinx
Elke Vandewyer
Yunhong Huang
Marta Ciesielska
Gerdien De Kloe
Sebastian Munck
Bart De Strooper
机构
[1] Vlaams Instituut voor Biotechnologie (VIB) Center for the Biology of Disease,Neuroscience Department
[2] Center for Human Genetics and Leuven Institute for Neuroscience and Disease (LIND),undefined
[3] University of Leuven (KU Leuven),undefined
[4] Johnson & Johnson Pharmaceutical Research and Development,undefined
[5] Janssen Pharmaceutica,undefined
来源
Nature Medicine | 2013年 / 19卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The mechanism whereby activation of G protein–coupled receptors (GPCRs) increase the production of amyloid-β (Aβ) peptide remains unclear. Here Bart De Strooper and colleagues show that the GPCR adaptor protein β-arrestin 2 promotes Aβ production by associating with APH-1A and increasing γ-secretase activity. Overexpression of β-arrestin 2 increases Aβ generation, whereas mice lacking β-arrestin 2 have reduced amyloid accumulation. Moreover, expression of β-arrestin 2 is elevated in individuals with Alzheimer's disease, suggesting a potential therapeutic target aimed at reducing amyloid production.
引用
收藏
页码:43 / 49
页数:6
相关论文
共 110 条
[1]  
Ballatore C(2007)Tau-mediated neurodegeneration in Alzheimer's disease and related disorders Nat. Rev. Neurosci. 8 663-672
[2]  
Lee VM(2012)Tau-targeted treatment strategies in Alzheimer's disease Br. J. Pharmacol. 165 1246-1259
[3]  
Trojanowski JQ(2011)Mapping the road forward in Alzheimer's disease Sci. Transl. Med. 3 114ps148-213
[4]  
Götz J(2011)Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift Neuron 69 203-712
[5]  
Ittner A(2011)The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics Nat. Rev. Drug Discov. 10 698-1506
[6]  
Ittner LM(2012)ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in AD mouse models Science 335 1503-1065
[7]  
Holtzman DM(2011)Resolving controversies on the path to Alzheimer's therapeutics Nat. Med. 17 1060-12
[8]  
Goate A(2003)Aph-1, Pen-2, and Nicastrin with Presenilin generate an active γ-Secretase complex Neuron 38 9-281
[9]  
Kelly J(2010)The genetics of Alzheimer disease: back to the future Neuron 68 270-227
[10]  
Sperling R(2010)Genetics of Alzheimer disease J. Geriatr. Psychiatry Neurol. 23 213-131